Sandoz and Civica Rx have entered into a long-term collaboration to help mitigate medicine shortages in US hospitals, where Sandoz will supply six critical injectables and Civica will ensure reliable supply of these medicines to patients.
Novartis’ Sandoz has announced a five-year agreement with Civica Rx, a non-profit organization, to manufacture and supply critical generic injectables in the US. Sandoz has confirmed that it will begin shipping the initial supply of medicines to Civica later this year.
While Sandoz has committed to supplying six critical injectables including antibiotics, acid reducers, blood thinners, blood pressure regulators and medicines...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
